• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于治疗注意力缺陷/多动障碍的哌甲酯的不良反应:结构及其与临床特征和症状控制的关联

Adverse reactions to methylphenidate treatment for attention-deficit/hyperactivity disorder: structure and associations with clinical characteristics and symptom control.

作者信息

Sonuga-Barke Edmund J S, Coghill David, Wigal Timothy, DeBacker Marc, Swanson James

机构信息

Institute for Disorders of Impulse and Attention, School of Psychology, University of Southampton, UK.

出版信息

J Child Adolesc Psychopharmacol. 2009 Dec;19(6):683-90. doi: 10.1089/cap.2009.0024.

DOI:10.1089/cap.2009.0024
PMID:20035586
Abstract

BACKGROUND

Methylphenidate (MPH)-related adverse events are well characterized. Their predictors and their relationship with therapeutic effects are less well understood. Here we examine these issues in relation to two long-acting formulations.

METHOD

Comparison of Methylphenidates in the Analog Classroom Setting (COMACS) was made in a large (n = 184) placebo-controlled trial comparing Equasym XL/Metadate CD, Concerta, and placebo (PLA) using a Laboratory School protocol. Therapeutic effects were measured using direct observation, scores on a simple math productivity task and parent ratings. Parents also completed the Barkley Stimulant Side Effect Rating Scale (BSSERS).

RESULTS

The BSSERS had six factors: Emotionality, sleep/appetite, disengaged, dizzy, uninterested, and aches. Treatment effects were seen only for emotionality (which improved) and sleep and appetite (which worsened). Adverse events were not predictable from personal and clinical characteristics of patients. Sleep/appetite adverse events were not associated with therapeutic effects. Improvements in attention-deficit/hyperactivity disorder (ADHD) and emotionality were correlated.

DISCUSSION

The results support a narrow conceptualization of MPH adverse events with problems restricted to appetite and sleep. These effects were not predictable on the basis of available information and may be due to an underlying mechanism rather distinct from those determining therapeutic effects.

摘要

背景

哌甲酯(MPH)相关的不良事件已得到充分描述。但其预测因素以及它们与治疗效果的关系尚不太清楚。在此,我们针对两种长效制剂研究这些问题。

方法

在一项大型(n = 184)安慰剂对照试验中,采用实验室学校方案,比较了Equasym XL/Metadate CD、康纳达(Concerta)和安慰剂(PLA),即模拟课堂环境中哌甲酯的比较研究(COMACS)。使用直接观察、简单数学生产率任务得分和家长评分来衡量治疗效果。家长们还完成了巴克利兴奋剂副作用评定量表(BSSERS)。

结果

BSSERS有六个因素:情绪、睡眠/食欲、注意力不集中、头晕、无兴趣和疼痛。仅在情绪(有所改善)以及睡眠和食欲(有所恶化)方面观察到治疗效果。不良事件无法根据患者的个人和临床特征预测。睡眠/食欲不良事件与治疗效果无关。注意力缺陷多动障碍(ADHD)的改善与情绪改善相关。

讨论

结果支持对MPH不良事件进行狭义的概念化,即问题仅限于食欲和睡眠。这些影响无法根据现有信息预测,可能是由于一种与决定治疗效果的机制截然不同的潜在机制。

相似文献

1
Adverse reactions to methylphenidate treatment for attention-deficit/hyperactivity disorder: structure and associations with clinical characteristics and symptom control.用于治疗注意力缺陷/多动障碍的哌甲酯的不良反应:结构及其与临床特征和症状控制的关联
J Child Adolesc Psychopharmacol. 2009 Dec;19(6):683-90. doi: 10.1089/cap.2009.0024.
2
Measuring methylphenidate response in attention-deficit/hyperactvity disorder: how are laboratory classroom-based measures related to parent ratings?测量注意力缺陷/多动障碍中哌甲酯的反应:基于实验室课堂的测量方法与家长评分有何关联?
J Child Adolesc Psychopharmacol. 2009 Dec;19(6):691-8. doi: 10.1089/cap.2009.0027.
3
Efficacy of two once-daily methylphenidate formulations compared across dose levels at different times of the day: preliminary indications from a secondary analysis of the COMACS study data.两种每日一次的哌甲酯制剂在一天中不同时间的不同剂量水平下的疗效比较:来自COMACS研究数据二次分析的初步迹象
BMC Psychiatry. 2004 Sep 30;4:28. doi: 10.1186/1471-244X-4-28.
4
Once-a-day Concerta methylphenidate versus three-times-daily methylphenidate in laboratory and natural settings.每日一次服用的盐酸哌甲酯控释片与每日三次服用的哌甲酯在实验室及自然环境中的对比研究。
Pediatrics. 2001 Jun;107(6):E105. doi: 10.1542/peds.107.6.e105.
5
Effect of transitioning from extended-release methylphenidate onto osmotic, controlled-release methylphenidate in children/adolescents with ADHD: results of a 3-month non-interventional study.在 ADHD 儿童/青少年中,从缓释哌甲酯转换为渗透控释哌甲酯的效果:一项 3 个月非干预性研究的结果。
Curr Med Res Opin. 2011;27 Suppl 2:35-44. doi: 10.1185/03007995.2011.601733. Epub 2011 Jul 25.
6
Efficacy of two long-acting methylphenidate formulations in children with attention- deficit/hyperactivity disorder in a laboratory classroom setting.两种长效哌甲酯制剂在实验室课堂环境中对注意力缺陷/多动障碍儿童的疗效。
J Child Adolesc Psychopharmacol. 2005 Aug;15(4):637-54. doi: 10.1089/cap.2005.15.637.
7
Methylphenidate dosing: twice daily versus three times daily.哌甲酯给药:每日两次与每日三次。
Pediatrics. 1996 Oct;98(4 Pt 1):748-56.
8
Side effects of methylphenidate and dexamphetamine in children with attention deficit hyperactivity disorder: a double-blind, crossover trial.哌甲酯和右旋苯丙胺治疗儿童注意力缺陷多动障碍的副作用:一项双盲交叉试验
Pediatrics. 1997 Oct;100(4):662-6. doi: 10.1542/peds.100.4.662.
9
Heterogeneity in the pharmacodynamics of two long-acting methylphenidate formulations for children with attention deficit/hyperactivity disorder. A growth mixture modelling analysis.两种用于治疗注意力缺陷/多动障碍儿童的长效哌醋甲酯制剂的药效学异质性。一项生长混合模型分析。
Eur Child Adolesc Psychiatry. 2008 Jun;17(4):245-54. doi: 10.1007/s00787-007-0667-3.
10
Once-daily multilayer-release methylphenidate in a double-blind, crossover comparison to immediate-release methylphenidate in children with attention-deficit/hyperactivity disorder.每日一次多层释放型哌甲酯与速释型哌甲酯治疗儿童注意力缺陷/多动障碍的双盲交叉对照研究。
J Child Adolesc Psychopharmacol. 2007 Oct;17(5):675-88. doi: 10.1089/cap.2006.0101.

引用本文的文献

1
Add-On Supplement in Children with Attention-Deficit/Hyperactivity Disorder: A 12-Week Randomized Double-Blind Placebo-Controlled Clinical Trial.注意缺陷多动障碍儿童的补充治疗:一项为期 12 周的随机、双盲、安慰剂对照临床试验。
Nutrients. 2024 Jul 13;16(14):2260. doi: 10.3390/nu16142260.
2
Ketogenic diet ameliorates attention deficit hyperactivity disorder in rats via regulating gut microbiota.生酮饮食通过调节肠道微生物群改善大鼠的注意缺陷多动障碍。
PLoS One. 2023 Aug 16;18(8):e0289133. doi: 10.1371/journal.pone.0289133. eCollection 2023.
3
Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).
哌醋甲酯治疗注意缺陷多动障碍(ADHD)儿童和青少年。
Cochrane Database Syst Rev. 2023 Mar 27;3(3):CD009885. doi: 10.1002/14651858.CD009885.pub3.
4
Offering Neurofeedback as an Intervention for Children with Attention Deficit/Hyperactivity Disorder in Indonesia: A Feasibility Study.在印度尼西亚为注意力缺陷多动障碍儿童提供神经反馈作为干预措施:一项可行性研究。
Kobe J Med Sci. 2021 Dec 24;67(4):E125-E136.
5
Outcomes of a 12-week ecologically valid observational study of first treatment with methylphenidate in a representative clinical sample of drug naïve children with ADHD.一项为期 12 周的、针对首次接受哌醋甲酯治疗的 ADHD 药物初治儿童的具有生态学效度的观察性研究结果。
PLoS One. 2021 Oct 21;16(10):e0253727. doi: 10.1371/journal.pone.0253727. eCollection 2021.
6
Pre-Existing Comorbid Emotional Symptoms Moderate Short-Term Methylphenidate Adverse Effects in a Randomized Trial of Children with Attention-Deficit/Hyperactivity Disorder.注意缺陷多动障碍儿童随机试验中,预先存在的共病情绪症状中度短期哌醋甲酯不良反应。
J Child Adolesc Psychopharmacol. 2020 Apr;30(3):137-147. doi: 10.1089/cap.2019.0125. Epub 2019 Dec 16.
7
Prediction of sleep side effects following methylphenidate treatment in ADHD youth.预测 ADHD 青少年使用哌醋甲酯治疗后的睡眠副作用。
Neuroimage Clin. 2020;26:102030. doi: 10.1016/j.nicl.2019.102030. Epub 2019 Oct 21.
8
Sweat it out? The effects of physical exercise on cognition and behavior in children and adults with ADHD: a systematic literature review.通过运动出汗来改善?体育锻炼对患有注意力缺陷多动障碍的儿童和成人认知及行为的影响:一项系统文献综述
J Neural Transm (Vienna). 2017 Feb;124(Suppl 1):3-26. doi: 10.1007/s00702-016-1593-7. Epub 2016 Jul 11.
9
The Effects of Classroom Interventions on Off-Task and Disruptive Classroom Behavior in Children with Symptoms of Attention-Deficit/Hyperactivity Disorder: A Meta-Analytic Review.课堂干预对患有注意力缺陷/多动障碍症状儿童的任务无关及破坏性行为的影响:一项元分析综述
PLoS One. 2016 Feb 17;11(2):e0148841. doi: 10.1371/journal.pone.0148841. eCollection 2016.
10
Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).用于治疗儿童和青少年注意力缺陷多动障碍(ADHD)的哌甲酯。
Cochrane Database Syst Rev. 2015 Nov 25;2015(11):CD009885. doi: 10.1002/14651858.CD009885.pub2.